Current Management of In-Stent Restenosis

Ae Young Her; Eun Seok Shin

doi:10.4070/kcj.2018.0103

Current Management of In-Stent Restenosis

Korean Circ J. 2018 May;48(5):337-349. doi: 10.4070/kcj.2018.0103.

Authors

Ae Young Her¹, Eun Seok Shin²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
² Division of Cardiology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea. sesim1989@gmail.com.

Abstract

Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compared the available options for treating ISR in an attempt to identify the preferred therapeutic strategy. In this review, we will discuss the currently available therapeutic strategies for the management of patients with ISR and the evidence supporting their use.

Keywords: Angioplasty; Balloon; Coronary; Drug-eluting stent; Restenosis.

Publication types

Review